Financials

  • Market Capitalization 442.19 M
  • Employee 35
  • Founded 2000
  • CEO N/A
  • Website www.diamedica.com
  • Headquarter Canada (Federal Level)
  • FIGI BBG000LP4YD7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2917
SLN
Silence Therapeutics Plc - American Depository Share
9.65 USD-2.13%-4.64%-24.96%+71.71%455.93 M USD
2929
YDES
YD Bio Limited - Ordinary Shares
6.33 USD-5.94%-8.79%+57.86%-65.60%448.10 M USD
2947
TECX
Tectonic Therapeutic, Inc. - Common Stock
22.35 USD-4.20%-3.46%-23.95%+30.32%436.93 M USD
2953
CAPR
Capricor Therapeutics, Inc. - Common Stock
7.47 USD-4.60%-3.24%-18.72%+12.84%434.30 M USD

Frequently asked questions about DiaMedica Therapeutics Inc. Common Stock

What is the DiaMedica Therapeutics Inc. Common Stock stock price today?

The current price of DiaMedica Therapeutics Inc. Common Stock (DMAC) is 8.20. Over the past 24 hours, the stock has changed by -1.56%. Follow the DMAC chart for real-time price dynamics.

What is the stock ticker of DiaMedica Therapeutics Inc. Common Stock?

DiaMedica Therapeutics Inc. Common Stock trades under the ticker DMAC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is DiaMedica Therapeutics Inc. Common Stock stock going up?

DMAC has changed by -3.53% over the last week, +26.35% over the last month, and +16.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of DiaMedica Therapeutics Inc. Common Stock?

DiaMedica Therapeutics Inc. Common Stock currently has a market capitalization of 442.19 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were DiaMedica Therapeutics Inc. Common Stock earnings last quarter?

Last quarter, DiaMedica Therapeutics Inc. Common Stock reported earnings of -0.19 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was DiaMedica Therapeutics Inc. Common Stock net income for the last quarter?

DiaMedica Therapeutics Inc. Common Stock reported net income of -10.14 M for the last quarter. The previous quarter showed -10.04 M, which means net income changed by -0.97%.

How many employees does DiaMedica Therapeutics Inc. Common Stock have?

As of the latest available data, DiaMedica Therapeutics Inc. Common Stock has 35 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy DiaMedica Therapeutics Inc. Common Stock stock?

You can buy DiaMedica Therapeutics Inc. Common Stock (DMAC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in DiaMedica Therapeutics Inc. Common Stock stock?

Investing in DiaMedica Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DMAC chart and related analysis on metatrader.com as part of your research.

News